Exact Sciences Corp (NAS:EXAS)
$ 53.52 2.52 (4.94%) Market Cap: 9.88 Bil Enterprise Value: 11.78 Bil PE Ratio: 0 PB Ratio: 3.14 GF Score: 78/100

Exact Sciences Corp at Stifel Healthcare Conference Transcript

Nov 14, 2023 / 03:20PM GMT
Release Date Price: $63.46 (+7.07%)
Operator

Welcome back to the 2023 Stifel Healthcare Conferences. We are on the life sciences and diagnostics track here, and we are happy to have Exact Sciences with us as our next session. CFO, Jeff Elliott, has agreed to stop by and spend some time with us. Jeff, thanks a bunch for agreeing to do it.

Jeffrey T. Elliott
Exact Sciences Corporation - Executive VP & CFO

Thank you, and thanks to the entire Stifel team.

Questions & Answers

Unidentified Analyst;Jeffrey T. Elliott
Exact Sciences Corporation - Executive VP & CFO<

Yes. Our pleasure. Maybe we can just start, Jeff, with A bit of a 3Q review maybe perhaps above consensus for the quarter, 31% growth in screening, 3% growth for precision oncology and EBITDA was above the street as well, which I think has been a focus for you guys for a couple of quarters now.

Maybe just sum up, given that level of performance and the consistency that you've had truthfully over the course of the year, how you feel going into year-end?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot